SCHEMBL11074992

SCHEMBL11074992

CCCCn1c(=S)c2c(ncn2CC(C)=O)n(CCCC)c1=O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 11/20 0.77
PDE4B Q07343 10/20 0.77
PDE4C Q08493 10/20 0.77
PDE4D Q08499 10/20 0.77
ADORA2A P29274 6/20 0.77
ADORA2B P29275 3/20 0.77
MEN1 O00255 1/20 0.47
ALDH1A1 P00352 1/20 0.47
KMT2A Q03164 1/20 0.47
LMNA P02545 1/20 0.46
ESR1 P03372 1/20 0.46
CYP1A2 P05177 1/20 0.46
MAPT P10636 1/20 0.46
NFKB1 P19838 1/20 0.46
ACHE P22303 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
TRPA1 O75762 1/20 0.46
BRD4 O60885 1/20 0.46
BRD2 P25440 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11077732 0.96 PDE4A (0.72) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL11078871 0.90 PDE4A (0.66) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL11076878 0.89 PDE4A (0.63) PDE4APDE4BPDE4CPDE4DADORA2A
Denbufylline SCHEMBL127152 0.87 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DADORA2A
Denbufylline SCHEMBL7299526 0.87 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DADORA2A
Denbufylline SCHEMBL11044404 0.86 PDE4A (0.97) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL11078800 0.86 PDE4A (0.60) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL10872056 0.85 PDE4A (0.95) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL7323464 0.84 PDE4A (0.93) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL9853393 0.84 PDE4A (0.80) PDE4APDE4BPDE4CPDE4DADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4454138-A TREATMENT OF VASCULAR DISEASES Wuelfing, Johann A. (DE) 1984-06-12 US disclosed
EP-0018136-A1 Xanthine derivatives, a process for their preparation and their use in pharmaceutical compositions BEECHAM - WUELFING GmbH & Co. KG (DE) 1980-10-29 EP disclosed